MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


GlobalData funds Deallus acquisition through new debt facility

ALN

GlobalData PLC on Tuesday said its Healthcare division has completed its acquisition of Deallus Consulting Ltd, a competitive intelligence solutions provider focused on the life sciences sector.

The London-based analytics and consultancy firm said it funded the takeover through its new £340 million debt facility, announced on December 19, though the sum of the transaction on Tuesday was not disclosed.

The facility included a £176.6 million facility for its Healthcare business, of which £61.8 million was allocated to an acquisition credit facility, and the remaining £114.8 million to a revolving credit facility.

The separate £163.4 million facility for the rest of the group comprised of a £44.2 million acquisition facility and a £119.2 million revolving facility.

Deallus was the fourth acquisition made by GlobalData during the second half of its financial year, in addition to Business Trade Media International, LinkUp and Celent, as part of its ongoing growth transformation plan.

Chief Executive Officer Mike Danson said: ‘This acquisition further enhances our capabilities in delivering life sciences solutions, allowing us to deliver even more comprehensive insights and services to our clients. Deallus’s deep sector expertise and client-first mindset perfectly align with our mission to empower decision-makers in navigating the complexities of the healthcare landscape. Together, we are poised to drive remarkable growth and deliver exceptional value to our stakeholders.’

GlobalData is due to issue an update on its trading and full-year results on January 14.

Shares in GlobalData were up 0.7% at 203.50 pence each in London on Tuesday morning.

Copyright 2025 Alliance News Ltd. All Rights Reserved.